The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) delivered a statement at the 2026 UN High-Level Meeting on HIV/AIDS in New York, reaffirming support for global efforts to end AIDS as a public health threat by 2030.
In its address, IFPMA welcomed the Political Declaration adopted by Member States and emphasized the need for country-led, evidence-based implementation strategies to sustain progress in HIV prevention, treatment, and care. The organization noted that while significant advances have been achieved, continued political commitment, funding, and collaboration remain essential - Read More
The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) delivered a statement at the 2026 UN High-Level Meeting on HIV/AIDS in New York, reaff...
BinSina Pharmacy is celebrating its 59th anniversary through brand activations and giveaways thanking communities across the UAE for their support and trust. Founded i...
Grünenthal today announced the acquisition of US-based Valinor Pharma, LLC (“Valinor”) and its product Movantik® (naloxegol), with a total deal value of approx. 0 million...
Equity is a value in the Danish healthcare system, and healthcare is an important part of its welfare system, resulting in a heavily financed public funds system, experie...
Companies in the pharmaceutical, medical goods and life science industries are currently evaluating the packaging concepts that are used for their products. The reason –...
A virtual marketplace leading your business into the future
